5-Aminolevulinic acid fermentation using engineered Saccharomyces cerevisiae
- 253 Downloads
5′-Aminolevulinic acid (ALA) is widely used in the pharmaceutical industry, healthcare, and food production, and is a substrate for the biosynthesis of heme, which is required for respiration and photosynthesis. Enhancement of ALA biosynthesis has never been developed in Saccharomyces cerevisiae, which is a well-known model microorganism used for bioproduction of many value-added compounds.
We demonstrated that metabolic engineering significantly improved ALA production in S. cerevisiae. First, we found that overexpression of HEM1, which encodes ALA synthetase, increased ALA production. Furthermore, addition of an optimal amount of glycine, a substrate for ALA biosynthesis, or levulinic acid, an inhibitor of ALA dehydrogenase, effectively increased ALA production. Next, we developed an assay for multiple metabolites including ALA and found that aconitase, encoded by ACO1 and ACO2, is the rate-limiting enzyme of ALA biosynthesis when sufficient glycine is supplied. Overexpression of ACO2 further enhanced ALA production in S. cerevisiae overexpressing HEM1.
Keywords5′-Aminolevulinic acid Yeast Saccharomyces cerevisiae Metabolic engineering Cell factory
5′-Aminolevulinic acid (ALA) is an industrial fine chemical, and has important physiological functions in humans and other organisms, including acting as a substrate for heme biosynthesis [1, 2, 3, 4, 5]. ALA has been widely used not only as a human healthcare product, but also as an additive in food and fertilizer. In recent years, demand for ALA has increased [2, 4].
ALA biosynthesis occurs via two routes. One is the C5 pathway, which involves three enzymatic reactions and is found in most eubacteria, and in all archaebacteria, algae and plants . In the C5 pathway, tRNA for l-glutamic acid is glutamylated by glutamyl-tRNA synthetase and the resultant l-glutamyl-tRNA(Glu) is then converted to l-glutamate 1-semialdehyde by glutamyl-tRNA reductase. Finally, l-glutamate 1-semialdehyde is converted to ALA, catalyzed by glutamate-1-semialdehyde aminotransferase. The other route to synthesize ALA is the C4 pathway (Shemin pathway) found in animals and fungi. ALA production in the C4 pathway in Corynebacterium glutamicum has been improved through metabolic engineering . The C4 pathway depends on the condensation of succinyl-coenzyme A (CoA) and glycine by ALA synthetase (EC 188.8.131.52) . At present, Rhodobacter sphaeroides is industrially used to produce ALA via the C4 pathway . However, R. sphaeroides cannot be improved through metabolic engineering or synthetic bioengineering.
Saccharomyces cerevisiae is a well-studied microorganism, and genetic and metabolic information on it are abundant. S. cerevisiae is also “generally recognized as safe”, and commonly used for production of fine chemicals, such as healthcare supplements, food additives, functional feeds, and supplemental fertilizers . An additional advantage of S. cerevisiae is tolerance of acidic conditions, enabling production of products such as amino and organic acids. The cellular ability for fine chemical production in S. cerevisiae can be enhanced by random mutagenesis, metabolic engineering, and recently, synthetic bioengineering . However, ALA production in S. cerevisiae has never been assessed, although there is potential for its improvement through metabolic engineering based on the abundant genetic information and manipulation tools available for this organism.
ALA production in S. cerevisiae
ALA production using HEM1-overexpressing S. cerevisiae
To enhance ALA production, HEM1—which encodes ALA synthetase, an enzyme involved in the heme assimilation system in S. cerevisiae (Fig. 1)—was overexpressed. ALA fermentation was performed using a vector control strain and a HEM1-overexpressing strain. We compared their cell concentrations (growth), intracellular ALA content, and volumetric ALA concentrations after 24 and 48 h of cultivation (Fig. 2). As shown in Fig. 2a, the cell concentration of the HEM1-overexpressing strain (0.90 and 1.14 g-cell/L at 24 and 48 h, respectively) was 0.66 and 0.78-fold that of the control strain (1.36 and 1.46 g-cell/L). However, as shown in Fig. 2b, the intracellular ALA content of the HEM1-overexpressing strain (0.24 and 0.14 mg/g dry cell weight [DCW]) was 5.7- and 4.2-fold that in the control strain (0.042 and 0.033 mg/g DCW) at 24 and 48 h, respectively. In the HEM1-overexpressing strain, considering the total effect of the decrease in the cell concentration (Fig. 2a) and the increase in the intracellular ALA content (Fig. 2b), the volumetric ALA concentration was increased during fermentation (Fig. 2c): the volumetric ALA concentration for the HEM1-overexpressing strain (0.22 and 0.15 mg/L at 24 and 48 h, respectively) was 3.8- and 3.2-fold that for the control strain (0.058 and 0.048 mg/L, respectively).
Effect of levulinic acid addition on ALA production by S. cerevisiae
Effect of glycine addition on ALA production in S. cerevisiae
Glycine is a substrate for ALA biosynthesis, and glycine addition has been shown to enhance ALA production in C. glutamicum . To enhance ALA production in S. cerevisiae, glycine was added to culture of the HEM1-overexpressing strain in the absence of levulinic acid. We compared cell concentrations (growth), intracellular ALA content, and volumetric ALA concentrations (Fig. 3). As shown in Fig. 3a, the cell concentration of the HEM1-overexpressing strain was increased by addition of 1 mM glycine, and decreased by > 10 mM glycine. The intracellular ALA content of the HEM1-overexpressing strain was increased by addition of 0–5 mM glycine, and decreased by 5–100 mM added glycine (Fig. 3b). Considering the changes in cell concentration (Fig. 3a) and the intracellular ALA content (Fig. 3b), the volumetric ALA concentration was maximized by addition of 5 mM glycine to culture of the HEM1-overexpressing S. cerevisiae strain (Fig. 3c). The maximized volumetric ALA concentration produced by the HEM1-overexpressing strain after cultivation for 24 h with 5 mM glycine addition reached up to 14.4-fold that with no glycine addition.
Additional overexpression of ACO1 and ACO2 in HEM1-overexpressing S. cerevisiae in the presence of glycine
Effect of glycine addition to HEM1-overexpressing Saccharomyces cerevisiae culture on intracellular citrate and isocitrate levels
Added glycine concentration (mM)
Citrate + isocitrate content (%)
Glycine content (%)
To elucidate whether there was a shortage of isocitrate in the HEM1-overexpressing strain when glycine was supplied, we overexpressed Aco1 and Aco2 in this strain (see Fig. 1). ACO1 and ACO2 are annotated as encoding aconitase  and putative mitochondrial aconitase isozyme , respectively, in the Saccharomyces Genome Database (https://www.yeastgenome.org/). Their overexpression was confirmed by measuring the relative mRNA levels of the ACO1 and ACO2 genes by reverse transcription quantitative PCR (RT-qPCR) (Additional file 1: Figure S1).
The intracellular ALA content in the HEM1 single-overexpression strain and that in the HEM1/ACO1 and HEM1/ACO2 double-overexpression strains were compared using the metabolic assay we developed. We found that the intracellular ALA content in the HEM1/ACO1 double-overexpression strain was almost the same as that in the HEM1 single-overexpression strain. However, the intracellular ALA content in the HEM1/ACO2 double-overexpression strain (1.38 and 1.29 mg/g DCW) was 3.7- and 4.4-fold that in the HEM1 single-overexpression strain at 24 and 48 h, respectively. As a result of the equal cell growth but increased intracellular ALA content in the HEM1/ACO2 double-overexpression strain when glycine was added to the culture, the volumetric ALA concentration in this strain (1.31 and 1.36 mg/L) was 3.7- and 4.4-fold that in the HEM1 single-overexpression strain at 24 and 48 h, respectively.
In this study, we improved ALA production in S. cerevisiae through metabolic engineering of the heme biosynthesis pathway (Fig. 1). Overexpression of HEM1, encoding ALA synthetase, increased ALA production more than threefold (Fig. 2c), although expression of this gene resulted in decreased cell growth (Fig. 2a). The reason the intracellular ALA content after cultivation for 48 h was lower than that after 24 h (Fig. 2b) was because of the metabolism of ALA into heme and dimerization of ALA. The increase in ALA biosynthesis by overexpression of ALA synthetase was similar to that observed in C. glutamicum . HEM2 encodes 5-aminolevulinate dehydratase, which catalyzes the conversion of ALA to porphobilinogen in heme biosynthesis. Thus, it is expected that deletion of HEM2 would further enhance ALA biosynthesis. However, in our study, such clones did not grow after the introduction of a PCR fragment to delete HEM2. This result indicates that porphobilinogen synthesis is critical to supply the heme that is essential for cell growth of S. cerevisiae. Previously, in Escherichia coli, direct engineering of the hemB open reading frame (corresponding to HEM2 in S. cerevisiae) to inhibit ALA dehydrogenase activity increased ALA accumulation . Therefore, we tested the addition of levulinic acid, an inhibitor of ALA dehydrogenase, to culture of HEM1-expressing S. cerevisiae [12, 13]; as expected, levulinic acid addition enhanced ALA production (Fig. 3a–c). This result indicates the possibility to enhance ALA production through intracellular biosynthesis of levulinic acid by metabolic engineering.
In R. sphaeroides and C. glutamicum, glycine is critical in enhancing ALA production because ALA synthetase Hem1 converts it to ALA. Indeed, here, the addition of 5 mM glycine resulted in 4.0 mg/L ALA production in the HEM1 overexpressing S. cerevisiae (Fig. 3f), although a high concentration of glycine inhibited the growth of this strain (Fig. 3d). To improve ALA production, further metabolic engineering of S. cerevisiae is necessary.
Strains, plasmids, and media
NovaBlue (Novagen, Madison, WI, USA) was used as the Escherichia coli host strain for recombinant DNA manipulation. S. cerevisiae YPH499 (ABC1193) (MATa ura3-52 lys2-801 ade2-101 trp1-Δ63 his3-Δ200 leu2-Δ1) was used as the parental strain for metabolic engineering.
E. coli transformants were grown in Luria–Bertani medium (10 g/L tryptone, 5 g/L yeast extract, and 5 g/L sodium chloride) supplemented with 100 µg/mL ampicillin. Yeast transformants were cultured in Sabouraud dextrose agar (SDA; 6.7 g/L yeast nitrogen base without amino acids, 20 g/L glucose, and appropriate concentrations of amino acids). All chemicals were purchased from Nacalai (Kyoto, Japan), or Wako (Osaka, Japan).
Plasmid construction and yeast transformation
The HEM1 gene was amplified by PCR from S. cerevisiae YPH499 genomic DNA. The forward and reverse primers used for this amplification were: 5′-GGCCGCTAGCATGCAACGCTCCATTTTTGC-3′ (NheI site is underlined) and 5′-GGCCGGATCCTTACTGCTTGATACCACTAGAAAC-3′ (BamHI site is underlined). The amplified fragment was digested with NheI and BamHI, respectively, and inserted into the NheI/BamHI sites of pGK405 to construct pGK405-HEM1. ACO1 and ACO2 were also amplified by PCR from S. cerevisiae YPH499 genomic DNA. The forward and reverse primers used for amplification of the ACO1 gene were: 5′-GGCCGCTAGCATGCTGTCTGCACGTTCTGCC-3′ (NheI site is underlined) and 5′-GGCCGTCGACTTATTTCTTCTCATCGGCC-3′ (SalI site is underlined). The amplified fragment of the ACO1 gene was digested with NheI/SalI and inserted into the NheI/SalI sites of pGK406 to construct pGK406-ACO1. The forward and reverse primers used for amplification of the ACO2 gene were: 5′-GGCCGCTAGCATGCTATCTTCAGCTAATAGG-3′ (NheI site is underlined) and 5′-GGAACCCGGGTTATTCGTTTCTTCGTATATTACC-3′ (XmaI site is underlined). The amplified fragment of the ACO2 gene was digested with NheI/XmaI and inserted into the NheI/XmaI sites of pGK406 to construct pGK406-ACO2.
The S. cerevisiae YPH499 host strain was transformed with each plasmid (pGK405-HEM1, pGK406-ACO1, and pGK406-ACO2) digested by EcoRV. Transformants were selected by culture on SDA, and the insertions of the HEM1, ACO1, and ACO2 genes were confirmed by PCR of genomic DNA using appropriate primers.
Reverse transcription quantitative PCR
The relative mRNA levels of ACO1 and ACO2 were measured by RT-qPCR. Total RNA was extracted from yeast transformants by using NucleoSpin RNA Plus (Macherey–Nagel GmbH & Co., Düren, Germany). cDNA was synthesized using a PrimeScript™ RT Reagent Kit (Takara Bio Inc., Shiga, Japan), according to the manufacturer’s instructions. RT-qPCR was performed using a LightCycler® Nano system and FastStart Essential DNA Green Master (Roche Diagnostics, Mannheim, Germany). Expression levels of target transcripts (ACO1 and ACO2) were normalized to the ACT1 mRNA level for each strain. RT-qPCR for ACT1 and ACO1 was performed using primer sets described in previous study , and the primers for ACO2 (forward primer, 5′-AGGCTTATGACCTTGACGGAAC-3′; reverse primer, 5′-TCTTGCGGAACCTTCACCATAG-3′) were designed using the Primer3 plus program (https://primer3plus.com/).
ALA fermentation using S. cerevisiae mutant strains
Saccharomyces cerevisiae mutant strains were cultivated in 5 mL yeast extract-peptone-dextrose (10 g/L yeast extract, 20 g/L Bacto Peptone and 20 g/L glucose) liquid medium at 30 °C with agitation at 200 rpm overnight. Each culture was inoculated into 50 mL Synthetic Defined liquid medium (6.7 g/L yeast nitrogen base without amino acids and 20 g/L glucose) in a baffled Erlenmeyer flask to an initial optical density at 600 nm (OD600) of 0.06. Cultures were then grown at 30 °C with agitation at 120 rpm for 24–48 h.
Sample preparation for GC–MS analysis
For analysis of intracellular ALA content in S. cerevisiae, 15 mL of culture were collected after 24 and 48 h of cultivation. To quantify ALA, the culture containing yeast cells was centrifuged at 3000×g at − 20 °C for 5 min. Immediately, after centrifugation, cells were treated with a cold methanol method for quenching metabolism in yeast cells —5 mL of precooled 60% (v/v) methanol solution at − 50 °C was added to the cell pellet and mixed quickly by inversion. After centrifugation at 3000×g at − 20 °C for 5 min, the cell pellet was frozen in liquid nitrogen and dried under vacuum. Metabolites were extracted from lyophilized cells using the previously described chloroform–methanol–water method . The water phase of the extract solution (300 μL) was dried under vacuum and stored at − 80 °C until GC–MS analysis.
Dried extracts were derivatized using a method previously described [8, 17]. A fused silica capillary column (CP-Sil 8 CB low bleed, 30 m × 0.25 mm i.d., Film Thickness 0.25 µm; Varian Inc., Palo Alto, CA) was used for separation of the metabolites. A Shimadzu GCMS-QP-2010 system (Kyoto, Japan) was used for the detection of ALA and other metabolites. GC–MS analysis was performed using a modified method previously described . In particular, m/z 174 was added to the ion monitoring channels for detection of ALA. A calibration curve was obtained from the ratio of ion peak areas of ALA and adipic acid as an internal standard detected at m/z 111.
We are grateful to Dr. J. Ishii (Kobe University) for providing us with pGK405 and pGK406. We thank Edanz Group (http://www.edanzediting.com/ac) for editing a draft of this manuscript.
KYH, MS and KK designed the study and wrote the manuscript. HK, KM and HK conducted the experiments. YN and YHH advised on the project and were involved in revising the manuscript. TF and SW coordinated this study. AK contributed to the major funding support and managed the project. All authors read and approved the final manuscript.
This study was supported by the Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe, iBioK), MEXT, Japan, Grant-in-Aid for Scientific Research (C) 16K00616, and a JST-Mirai Program Grant Number JPMJMI17EJ.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
- 12.Erskine PT, Norton E, Cooper JB, Lambert R, Coker A, Lewis G, Spencer P, Sarwar M, Wood SP, Warren MJ, Shoolingin-Jordan PM. X-ray structure of 5-aminolevulinic acid dehydratase from Escherichia coli complexed with the inhibitor levulinic acid at 2.0 A resolution. Biochemistry. 1999;38:4266–76.CrossRefGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.